«Disruptive technology for the treatment of hemophilia: New
therapy decreases incidence of bleeding by nearly 90 percent.»
Not exact matches
Since the report that it did cause breast cancer and many women have stopped taking hormone replacement
therapy, we've seen a
decrease in breast - cancer
incidence, exactly what you'd predict for our understanding of how estrogens work.
After adjusting for clinical factors in a multivariate model, a CNA in a CFS was determined to be a significant independent predictor of
decreased response to radiation
therapy and higher
incidence of recurring cancer.
An international team of hematologists including Guy Young, MD, of Children's Hospital Los Angeles, has found that in patients with hemophilia A with inhibitors, a novel
therapy called emicizumab,
decreases incidence of bleeding episodes by 87 %.
«Since the slight
decrease in cancer mortality largely reflects changing
incidence or earlier detection, rather than improved
therapy, the logical next step, we believe, would be to shift more resources into an arena where we have proved that they make a difference and concentrate our efforts on prevention and early detection of cancer,» says Bailar.